|
⚲
|
| Keyboard |
| PhaseBio Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0001169245 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001169245] | |
| 10-Q | [0001169245] | |
| 3 | [0001169245] | |
| 4 | [0001169245] | |
| 8-K | [0001169245] | |
| D | [0001169245] | |
| SC 13D | [0001169245] | |
| SC 13G | [0001169245] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Grant | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 2,538 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 2,538 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 3,750 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 3,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-10-25 | Sell | 1,784,109 | $0.15 | 267,616 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-23 | Sell | 11,248 | $0.79 | 8,886 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-20 | Grant | 11,248 | $0.68 | 7,649 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-20 | Grant | 10,917 | $0.68 | 7,424 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-20 | Grant | 10,918 | $0.68 | 7,424 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2022-05-20 | Grant | 4,831 | $0.68 | 3,285 |
| showing 20 of 200 most recent transactions | |||||